Evaluation of the therapeutic potential of bone Marrow-Derived Myeloid Suppressor Cell (MDSC) adoptive transfer in mouse models of autoimmunity and allograft rejection

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Drujont, Lucile ^a   Carretero Iglesia, Laura ^a   Bouchet Delbos, Laurence ^a   Beriou, Gaelle ^a   Merieau, Emmanuel ^a   Hill, Marcelo ^a,c   Delneste, Yves ^b   Cuturi, Maria Cristina ^a   Louvet, Cedric ^a  

^a Centre National de la Recherche Scientifique   (France)

^b UNIVERSITÉ D'ANGERS   (France)

^c UNIVERSIDAD DE LA REPÚBLICA   (Uruguay)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 6; LIPOPOLYSACCHARIDE;

ADOPTIVE TRANSFER; ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; AUTOIMMUNITY; BONE MARROW CELL; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; IN VITRO STUDY; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; MYELOID DERIVED SUPPRESSOR CELL; NONHUMAN; SKIN TRANSPLANTATION; T LYMPHOCYTE ACTIVATION; ALLOGRAFT; ANIMAL; AUTOIMMUNE DISEASES; BONE MARROW TRANSPLANTATION; C57BL MOUSE; CELL CULTURE; CHLOROCEBUS AETHIOPS; COS 1 CELL LINE; DISEASE MODEL; IMMUNOLOGY; PATHOLOGY; PHYSIOLOGY; PROCEDURES; TRANSGENIC MOUSE; TRANSPLANTATION;

ADOPTIVE TRANSFER; ALLOGRAFTS; ANIMALS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; COS CELLS; DISEASE MODELS, ANIMAL; FEMALE; GRAFT REJECTION; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MYELOID CELLS;

EID: 84902809472     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0100013     Document Type: Article

References (49)

1. Gabrilovich DI, Nagaraj S (2009) Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 9: 162-174.
2. Peranzoni E, Zilio S, Marigo I, Dolcetti L, Zanovello P, et al. (2010) Myeloid-derived suppressor cell heterogeneity and subset definition. Curr Opin Immunol 22: 238-244.
3. Gabrilovich DI, Ostrand-Rosenberg S, Bronte V (2012) Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol 12: 253-268.
4. Dilek N, Vuillefroy de Silly R, Blancho G, Vanhove B (2012) Myeloid-derived suppressor cells: mechanisms of action and recent advances in their role in transplant tolerance. Front Immunol 3: 208.
5. Ochando JC, Chen SH (2012) Myeloid-derived suppressor cells in transplantation and cancer. Immunol Res 54: 275-285.
6. Cripps JG, Gorham JD (2011) MDSC in autoimmunity. Int Immunopharmacol 11: 789-793.
7. Yin B, Ma G, Yen CY, Zhou Z, Wang GX, et al. (2010) Myeloid-derived suppressor cells prevent type 1 diabetes in murine models. J Immunol 185: 5828-5834.
8. Hu C, Du W, Zhang X, Wong FS, Wen L (2012) The role of Gr1+ cells after anti-CD20 treatment in type 1 diabetes in nonobese diabetic mice. J Immunol 188: 294-301.
9. Fujii W, Ashihara E, Hirai H, Nagahara H, Kajitani N, et al. (2013) Myeloid-derived suppressor cells play crucial roles in the regulation of mouse collagen-induced arthritis. J Immunol 191: 1073-1081.
10. Haile LA, von Wasielewski R, Gamrekelashvili J, Kruger C, Bachmann O, et al. (2008) Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway. Gastroenterology 135: 871-881, e871-875.
11. Singh V, Mueller U, Freyschmidt-Paul P, Zoller M (2011) Delayed type hypersensitivity-induced myeloid-derived suppressor cells regulate autoreactive T cells. Eur J Immunol 41: 2871-2882.
12. Valaperti A, Marty RR, Kania G, Germano D, Mauermann N, et al. (2008) CD11b+ monocytes abrogate Th17 CD4+ T cell-mediated experimental autoimmune myocarditis. J Immunol 180: 2686-2695.
13. Zehntner SP, Brickman C, Bourbonniere L, Remington L, Caruso M, et al. (2005) Neutrophils that infiltrate the central nervous system regulate T cell responses. J Immunol 174: 5124-5131.
14. Zhu B, Bando Y, Xiao S, Yang K, Anderson AC, et al. (2007) CD11b+Ly-6C(hi) suppressive monocytes in experimental autoimmune encephalomyelitis. J Immunol 179: 5228-5237.
15. Ioannou M, Alissafi T, Lazaridis I, Deraos G, Matsoukas J, et al. (2012) Crucial role of granulocytic myeloid-derived suppressor cells in the regulation of central nervous system autoimmune disease. J Immunol 188: 1136-1146.
16. Zhang W, Liang S, Wu J, Horuzsko A (2008) Human inhibitory receptor immunoglobulin-like transcript 2 amplifies CD11b+Gr1+ myeloid-derived suppressor cells that promote long-term survival of allografts. Transplantation 86: 1125-1134.
17. Dugast AS, Haudebourg T, Coulon F, Heslan M, Haspot F, et al. (2008) Myeloid-derived suppressor cells accumulate in kidney allograft tolerance and specifically suppress effector T cell expansion. J Immunol 180: 7898-7906.
18. De Wilde V, Van Rompaey N, Hill M, Lebrun JF, Lemaitre P, et al. (2009) Endotoxin-induced myeloid-derived suppressor cells inhibit alloimmune responses via heme oxygenase-1. Am J Transplant 9: 2034-2047.
19. Garcia MR, Ledgerwood L, Yang Y, Xu J, Lal G, et al. (2010) Monocytic suppressive cells mediate cardiovascular transplantation tolerance in mice. J Clin Invest 120: 2486-2496.
20. Dilek N, Poirier N, Usal C, Martinet B, Blancho G, et al. (2012) Control of transplant tolerance and intragraft regulatory T cell localization by myeloidderived suppressor cells and CCL5. J Immunol 188: 4209-4216.
21. Wu T, Sun C, Chen Z, Zhen Y, Peng J, et al. (2012) Smad3-deficient CD11b(+)Gr1(+) myeloid-derived suppressor cells prevent allograft rejection via the nitric oxide pathway. J Immunol 189: 4989-5000.
22. Luan Y, Mosheir E, Menon MC, Wilson D, Woytovich C, et al. (2013) Monocytic Myeloid-Derived Suppressor Cells Accumulate in Renal Transplant Patients and Mediate CD4(+) Foxp3(+) Treg Expansion. Am J Transplant 13: 3123-3131.
23. Leslie M (2011) Immunology. Regulatory T cells get their chance to shine. Science 332: 1020-1021.
24. Adeegbe D, Serafini P, Bronte V, Zoso A, Ricordi C, et al. (2011) In vivo induction of myeloid suppressor cells and CD4(+)Foxp3(+) T regulatory cells prolongs skin allograft survival in mice. Cell Transplant 20: 941-954.
25. Turnquist HR, Zhao Z, Rosborough BR, Liu Q, Castellaneta A, et al. (2011) IL-33 expands suppressive CD11b+ Gr-1(int) and regulatory T cells, including ST2L+ Foxp3+ cells, and mediates regulatory T cell-dependent promotion of cardiac allograft survival. J Immunol 187: 4598-4610.
26. Rossner S, Voigtlander C, Wiethe C, Hanig J, Seifarth C, et al. (2005) Myeloid dendritic cell precursors generated from bone marrow suppress T cell responses via cell contact and nitric oxide production in vitro. Eur J Immunol 35: 3533-3544. (Pubitemid 43025534)
27. Zhou Z, French DL, Ma G, Eisenstein S, Chen Y, et al. (2010) Development and function of myeloid-derived suppressor cells generated from mouse embryonic and hematopoietic stem cells. Stem Cells 28: 620-632.
28. Chou HS, Hsieh CC, Charles R, Wang L, Wagner T, et al. (2011) Myeloid-Derived Suppressor Cells Protect Islet Transplants By B7-H1 Mediated Enhancement of T Regulatory Cells. Transplantation.
29. Guan Q, Moreno S, Qing G, Weiss CR, Lu L, et al. (2013) The role and potential therapeutic application of myeloid-derived suppressor cells in TNBS-induced colitis. J Leukoc Biol 94: 803-811.
30. Nefedova Y, Huang M, Kusmartsev S, Bhattacharya R, Cheng P, et al. (2004) Hyperactivation of STAT3 is involved in abnormal differentiation of dendritic cells in cancer. J Immunol 172: 464-474. (Pubitemid 38020502)
31. Eruslanov E, Daurkin I, Ortiz J, Vieweg J, Kusmartsev S (2010) Pivotal Advance: Tumor-mediated induction of myeloid-derived suppressor cells and M2-polarized macrophages by altering intracellular PGE(2) catabolism in myeloid cells. J Leukoc Biol 88: 839-848.
32. Marigo I, Bosio E, Solito S, Mesa C, Fernandez A, et al. (2010) Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor. Immunity 32: 790-802.
33. Lechner MG, Liebertz DJ, Epstein AL (2010) Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells. J Immunol 185: 2273-2284.
34. Harbers SO, Crocker A, Catalano G, D'Agati V, Jung S, et al. (2007) Antibody-enhanced cross-presentation of self antigen breaks T cell tolerance. J Clin Invest 117: 1361-1369. (Pubitemid 46718424)
35. Colonna L, Catalano G, Chew C, D'Agati V, Thomas JW, et al. (2011) Therapeutic targeting of Syk in autoimmune diabetes. J Immunol 185: 1532-1543.
36. Obermajer N, Muthuswamy R, Lesnock J, Edwards RP, Kalinski P (2011) Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells. Blood 118: 5498-5505.
37. Tomihara K, Guo M, Shin T, Sun X, Ludwig SM, et al. (2010) Antigen-specific immunity and cross-priming by epithelial ovarian carcinoma-induced CD11b(+)Gr-1(+) cells. J Immunol 184: 6151-6160.
38. Yi H, Guo C, Yu X, Zuo D, Wang XY (2012) Mouse CD11b+Gr-1+ myeloid cells can promote Th17 cell differentiation and experimental autoimmune encephalomyelitis. J Immunol 189: 4295-4304.
39. Brennan TV, Tang Q, Liu FC, Hoang V, Bi M, et al. (2011) Requirements for prolongation of allograft survival with regulatory T cell infusion in lymphosufficient hosts. J Surg Res 169: e69-75.
40. Schmidt K, Zilio S, Schmollinger JC, Bronte V, Blankenstein T, et al. (2013) Differently immunogenic cancers in mice induce immature myeloid cells that suppress CTL in vitro but not in vivo following transfer. Blood 121: 1740-1748.
41. Sade-Feldman M, Kanterman J, Ish-Shalom E, Elnekave M, Horwitz E, et al. (2013) Tumor necrosis factor-alpha blocks differentiation and enhances suppressive activity of immature myeloid cells during chronic inflammation. Immunity 38: 541-554.
42. Ribechini E, Greifenberg V, Sandwick S, Lutz MB (2009) Subsets, expansion and activation of myeloid-derived suppressor cells. Med Microbiol Immunol 199: 273-281.
43. Highfill SL, Rodriguez PC, Zhou Q, Goetz CA, Koehn BH, et al. (2010) Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13. Blood 116: 5738-5747.
44. Tang Q, Bluestone JA, Kang SM (2011) CD4(+)Foxp3(+) regulatory T cell therapy in transplantation. J Mol Cell Biol 4: 11-21.
45. Nagaraj S, Youn JI, Gabrilovich DI (2013) Reciprocal relationship between myeloid-derived suppressor cells and T cells. J Immunol 191: 17-23.
46. Pan PY, Ma G, Weber KJ, Ozao-Choy J, Wang G, et al. (2010) Immune stimulatory receptor CD40 is required for T-cell suppression and T regulatory cell activation mediated by myeloid-derived suppressor cells in cancer. Cancer Res 70: 99-108.
47. Centuori SM, Trad M, LaCasse CJ, Alizadeh D, Larmonier CB, et al. (2012) Myeloid-derived suppressor cells from tumor-bearing mice impair TGF-beta-induced differentiation of CD4+CD25+ FoxP3+ Tregs from CD4+CD25-FoxP3-T cells. J Leukoc Biol 92: 987-997.
48. Kurts C, Heath WR, Carbone FR, Allison J, Miller JF, et al. (1996) Constitutive class I-restricted exogenous presentation of self antigens in vivo. J Exp Med 184: 923-930. (Pubitemid 26313550)
49. Hogquist KA, Jameson SC, Heath WR, Howard JL, Bevan MJ, et al. (1994) T cell receptor antagonist peptides induce positive selection. Cell 76: 17-27. (Pubitemid 24035278)